CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Blood drawprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01176253
NCT01176253N/ACompleted
CompareCT.gov

Detection of Human Beta Cell Death in T1DM by Methylation Specific PCR

City of Hope Medical Center·observational·Posted Aug 5, 2010·Updated May 1, 2015

In Brief

An observational study evaluating Blood draw for Type 1 Diabetes Mellitus. Completed, enrolled 6 participants across 2 sites.

Detailed Summary

To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 5, 2010
Enrollment StartJul 1, 2009
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 15.9 years ago

Interventions

Blood drawprocedure

Blood draw for Type I DM patients will be taken every 4 weeks for 1 year post diagnosis/healthy volunteers will have 1 blood draw